Associations between good days per month and migraine-related disease impact in the real-world: a post hoc analysis from the REVIEW study of eptinezumab in chronic migraine
- DOI
- 10.1186/s10194-025-02227-5
- Published
- 2025-11-26
- Container
- The Journal of Headache and Pain
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s10194-025-02227-5,
title = {Associations between good days per month and migraine-related disease impact in the real-world: a post hoc analysis from the REVIEW study of eptinezumab in chronic migraine},
author = {Fawad A. Khan and Steven P. Herzog and Ryan M. Smith and Dawn C. Buse and Seema Soni-Brahmbhatt and Susanne F. Awad and S. Wald Grossman and Divya Asher and Foram Patel and Charles Argoff},
year = {2025},
journal = {The Journal of Headache and Pain},
doi = {10.1186/s10194-025-02227-5},
url = {https://doi.org/10.1186/s10194-025-02227-5}
}RIS
TY - JOUR TI - Associations between good days per month and migraine-related disease impact in the real-world: a post hoc analysis from the REVIEW study of eptinezumab in chronic migraine AU - Fawad A. Khan AU - Steven P. Herzog AU - Ryan M. Smith AU - Dawn C. Buse AU - Seema Soni-Brahmbhatt AU - Susanne F. Awad AU - S. Wald Grossman AU - Divya Asher AU - Foram Patel AU - Charles Argoff PY - 2025 JO - The Journal of Headache and Pain DO - 10.1186/s10194-025-02227-5 UR - https://doi.org/10.1186/s10194-025-02227-5 ER -
APA
Khan, F. A., Herzog, S. P., Smith, R. M., Buse, D. C., Soni-Brahmbhatt, S., Awad, S. F., Grossman, S. W., Asher, D., Patel, F., & Argoff, C. (2025). Associations between good days per month and migraine-related disease impact in the real-world: a post hoc analysis from the REVIEW study of eptinezumab in chronic migraine. The Journal of Headache and Pain. https://doi.org/10.1186/s10194-025-02227-5
Source records
- crossref · retrieved 2026-09-27T01:34:56.229Z